MELDONIUM: EFFECTIVE ACTION POINTS

Abstract

The paper is focused on hypoxia and cell ischemia as universal pathogenetic mechanisms of disease development, which can be addressed by both etiotropic and pathogenetic therapy. The latter is represented by the so-called metabolic correctors. At present, one of the most widely used metabolic correctors is mildronate. The authors discuss the effectiveness of mildronate in various clinical situations and also present the relevant original findings.

Keywords

• tissue hypoxia
• metabolic disturbances
• coronary heart disease
• chronic heart failure
• metabolic correctors
• mildronate